|Articles|July 10, 2023
Achieving Ophthalmic Production with Jubilant HollisterStier
Author(s)Jubilant HollisterStier
Discovery why evaluating a CMO’s internal processes, facilities, capacity, capabilities, and communication is key to successful ophthalmic scale up and manufacturing.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FDA October 2025 Draft Guidance Sparks Industry Biosimilars Buzz
2
Adenovirus Vectors, Cyclodextrins and the Patient Experience: A Deep Dive
3
How Biopharma Navigates the 2026 Economic Shift
4
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
5